Cargando…
Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug
Drug resistance is a major obstacle in successful systemic therapy of metastatic cancer. We analyzed the involvement of cell cycle regulatory proteins in eliciting response to N (phosphonoacetyl)-L-aspartate (PALA), an inhibitor of de novo pyrimidine synthesis, in two metastatic variants of human ca...
Autores principales: | WANG, JIN, YIN, HAILIN, PANANDIKAR, ASHWINI, GANDHI, VARSHA, SEN, SUBRATA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501665/ https://www.ncbi.nlm.nih.gov/pubmed/26058363 http://dx.doi.org/10.3892/ijo.2015.3037 |
Ejemplares similares
-
A Study of Antimetabolites
Publicado: (1952) -
Problems in the Designing of Antimetabolites
por: Mautner, Henry G.
Publicado: (1960) -
Antimetabolite Treatment for Pancreatic Cancer
por: Valenzuela, Malyn May Asuncion, et al.
Publicado: (2014) -
Weak Interaction of the Antimetabolite Drug Methotrexate with a Cavitand Derivative
por: Preisz, Zsolt, et al.
Publicado: (2020) -
Modulation of the Ribonucleotide Reductase-Antimetabolite Drug Interaction in Cancer Cell Lines
por: Zhou, Jun, et al.
Publicado: (2010)